The recent headlines proclaiming a cure for a Mississippi baby who had been exposed to the HIV virus which causes AIDS have captivated the world. This child was born to an HIV positive mother who had not received any prenatal care to reduce the transmission of the virus. Dr. Hannah Gay, who treated the baby,[…]
Can Ritonavir Boosted Fosamprenavir Lead to a Cure for AIDS?
Anti-Retroviral / Anti-HIV, Drug Research & Development API, Patent Expiration 2017 Tags: AIDSHIV virusNorvirRitonavir Mar 07, 2013
Atazanavir Sulfate Gets a Nod at the 6th International AIDS Society Conference
Anti-Retroviral / Anti-HIV, Antiviral, Drug Research & Development API, Patent Expiration 2017 Tags: antiretroviralHIVNorvirRitonavir Jan 20, 2013
Atazanavir Sulfate, CAS No: 229975-97-7 is also known as the antiretroviral medication Reyataz. With the patent for Reyataz expiring on June 20, 2017 research and development teams are currently working on the development of a generic version of this vital drug. Indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection, atazanavir[…]
Ritonavir Boosts the Efficacy of Protease Inhibitors
Anti-Retroviral / Anti-HIV, Drug Research & Development API Tags: HIV infectionNorvirRitonavir May 18, 2012
Ritonavir is also known by it’s brand name Norvir. Marketed by Abbott Laboratories, Norvir will lose it’s patent on January 28, 2014. The patent for the pediatric exclusivity for ritonavir will also expire on July 28, 2014. With the generic possibilities coming near, researchers are clamoring to commence clinical trials of ritonavir. As an antiviral[…]
Darunavir Ethanolate – Anti-Retroviral / Anti-HIV Therapeutic
Anti-Retroviral / Anti-HIV, Drug Research & Development API Tags: Darunavir EthanolateHIVNorvir Jul 21, 2010
Darunavir Ethanolate CAS# 635728-49-3 is a second-generation protease inhibitor (PIs), designed specifically to overcome problems with the older agents in this class, such as indinavir. Darunavir was designed to form robust interactions with the protease enzyme from many strains of HIV, including strains from treatment-experienced patients with multiple resistance mutations to PIs. Darunavir is always[…]